DescriptionKimi AI is a multi-agent platform combining visual coding, web research, and 24/7 autonomous workflows.
DescriptionAn AI platform for drug discovery that identifies novel targets, predicts drug response, and optimizes clinical trials using multi-omics data.
Long context window support (200K tokens)Multi-language conversationDocument and file analysisWeb search integrationReasoning and analysis capabilities
Features
Novel target identification and prioritizationDrug response and efficacy predictionClinical trial outcome simulation and optimizationMulti-omics data analysis integrationBiomedical literature miningProprietary biological knowledge graph access
Pricing Tiers
Pricing Tiers
Free$0/free
Limited daily messages and context window
Pro
Pricing Tiers—
Platforms
Platforms
webiosandroid
Platforms
webapi
Pros
Pros
Advanced multi-modal capabilities enabling visual content and document processing within chat
Agent-based functionality automates complex workflows across websites and applications
Direct integration with spreadsheets, slides, and documents for seamless collaboration
Deep research capabilities support comprehensive information gathering and analysis tasks
Kimi Code feature provides technical assistance for developers and programmers
Pros
Integrates multi-omics data, literature, and trials for holistic target discovery
Proprietary biological knowledge graphs and generative AI models tailored for pharmacology
Part of an integrated AI drug discovery suite (with PandaOmics and Chemistry42)
Aims to de-risk early-stage R&D and reduce late-stage clinical failure
Developed by a company (Insilico Medicine) with a proven track record of AI-driven drug pipelines
Cons
Cons
Limited availability primarily in Chinese market with restricted international access
Smaller user base compared to ChatGPT limits community resources and third-party integrations
Language support heavily focused on Chinese with limited English optimization
Less established track record raises questions about long-term reliability and updates
Integration ecosystem smaller than competitors affecting workflow compatibility options
Cons
Extremely niche and complex, requiring significant domain expertise in biology and pharmacology
Not a tool for general data analytics or non-biotech applications
Pricing and access are likely enterprise-only and very costly
Performance and predictions require extensive validation in wet-lab settings